Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00886
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2019
Authors
Publisher
Frontiers Media SA